
NRBO P/E Ratio
P/E Ratio as of Dec 16, 2025: -0.55
Average-0.5557
Median-0.5500
Minimum-0.7700
Maximum-0.4400
-0.55
0.03 (5.77%)past month
The P/E ratio for NRBO is -0.55 as of Dec 16, 2025. This represents a increase of 25.00% compared to its 12-month average P/E ratio of -0.44. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
NeuroBo Pharmaceuticals Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
NeuroBo Pharmaceuticals Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing NeuroBo Pharmaceuticals Inc to industry peers.
NeuroBo Pharmaceuticals Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
NeuroBo Pharmaceuticals Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing NeuroBo Pharmaceuticals Inc to industry peers.
NRBO P/E Ratio Insights
See NeuroBo Pharmaceuticals Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in NRBO
Order type
Buy in
Order amount
Est. shares
0 shares
NRBO P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Dec 1, 2025 | $8.2577 | -0.55 |
| Nov 3, 2025 | $11.00 | -0.74 |
| Oct 1, 2025 | $11.33 | -0.76 |
| Sep 2, 2025 | $7.007 | -0.36 |
| Aug 1, 2025 | $6.699 | -0.34 |
| Jul 1, 2025 | $7.15 | -0.37 |
| Jun 2, 2025 | $7.1995 | -0.19 |
| May 1, 2025 | $8.382 | -0.23 |
| Apr 1, 2025 | $17.325 | -0.47 |
| Mar 3, 2025 | $15.95 | -0.34 |
| Feb 3, 2025 | $19.14 | -0.40 |
| Jan 2, 2025 | $23.21 | -0.49 |
NRBO End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.55 | +17.02% |
| 2024 | -0.47 | -63.28% |
| 2023 | -1.28 | +2,460.00% |
| 2022 | -0.05 | -97.31% |
| 2021 | -1.86 | -42.41% |
| 2020 | -3.23 | — |
FAQs About NeuroBo Pharmaceuticals Inc (NRBO) P/E ratio
The latest P/E ratio of NRBO is -0.55, as of Dec 16, 2025. This is calculated based on its current stock price and earnings per share (EPS).
NeuroBo Pharmaceuticals Inc’s last 12-month average P/E ratio is -0.44, compared to its current P/E ratio of -0.55. This reflects a increase of 25.00%.
NeuroBo Pharmaceuticals Inc’s current P/E ratio of -0.55 is higher than its last 12-month average P/E of -0.44. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
NeuroBo Pharmaceuticals Inc’s average P/E ratio over the last 3 years is -0.66. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
NeuroBo Pharmaceuticals Inc’s average P/E ratio over the last 5 years is -1.05. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.